DAC, ISAC, and Dual Payload ADC: Who Will Lead the Next Generation of ADC Technology Innovation?

DAC, ISAC, and Dual Payload ADC: Who Will Lead the Next Generation of ADC Technology Innovation?

If a few years ago, presenting a simple PowerPoint on the ADC field could impress without the need for future visions, cutting-edge technologies, or a vibrant pipeline forest, today, the ADC field requires substantial content to make an impact. This shift is attributed to advancements in industry technology and rising awareness. Data shows that from … Read more

Research Advances in Glutamate and γ-Aminobutyric Acid Homeostasis Imbalance in Major Depressive Disorder

Research Advances in Glutamate and γ-Aminobutyric Acid Homeostasis Imbalance in Major Depressive Disorder

【Citation Format】Li Mian, Tan Zhonglin, Wu Yue, et al. Research advances in glutamate and γ-aminobutyric acid homeostasis imbalance in major depressive disorder[J]. Chinese Journal of Nervous and Mental Diseases, 2023, 49(12): 758-764. 【Cite this article】LI Mian, TAN Zhonglin, WU Yue, et al. Research advances in glutamate and γ-aminobutyric acid homeostasis imbalance in major depressive disorder[J]. … Read more

The Amazing ‘Magic Bullet’ – Antibody-Drug Conjugates (ADCs)

The Amazing 'Magic Bullet' - Antibody-Drug Conjugates (ADCs)

The Concept and Development History of ADC The treatment of tumors has always undergone a continuous transformation from theory to application, breaking and transforming again. As early as a century ago, scholars proposed the concept of antibody-drug conjugates (ADCs), vividly calling them “magic bullets,” aimed at targeting specific antigens that may exist on the surface … Read more

Comprehensive Interpretation of Antibody-Drug Conjugates (ADC)

Comprehensive Interpretation of Antibody-Drug Conjugates (ADC)

Since the first use of cytotoxic chemicals to treat cancer, oncologists have been searching for ways to enhance efficacy without significantly increasing overall toxicity to patients. One of the methods attempted to improve the killing effect on tumor cells is the use of cytotoxic agents with potency at picomolar or lower levels (such as microtubule … Read more

Potential Efficacy of High-Dose Vitamin C in Terminal Cancer Treatment

Potential Efficacy of High-Dose Vitamin C in Terminal Cancer Treatment

Medical researchers are not only continuously developing new anti-tumor drugs but are also trying to find new uses for old drugs, hoping to alleviate the suffering caused by cancer and extend survival. High-dose vitamin C treatment for cancer is one of these methods, which is still under research. Many people may wonder how vitamin C, … Read more

Comparative Analysis of SMDC, ADC, and DAC in Cancer Treatment

Comparative Analysis of SMDC, ADC, and DAC in Cancer Treatment

To deliver chemotherapy drugs more effectively, small molecule drug conjugates (SMDC), antibody-drug conjugates (ADC), and degrader-antibody conjugates (DAC) have been explored and developed, providing selective delivery while improving the therapeutic index. What are their similarities and differences? What are their respective advantages? What is the current state of research? What does the future hold? This … Read more

Introduction to Decitabine (DAC)

Introduction to Decitabine (DAC)

Welcome to reprint, please note the source “Jiangcheng ITP Home”🎉🎉🎉 Decitabine (DAC) is commonly known as an anticancer drug, clinically used for the treatment of myelodysplastic syndromes (MDS), acute myeloid leukemia, chronic myelomonocytic leukemia, and other malignant hematological diseases,because it has demethylation and cytotoxic effects, which can induce cell death. However, its “magical” efficacy in … Read more

15 ADC Drugs: Dosage and Usage Summary

15 ADC Drugs: Dosage and Usage Summary

Currently, there are 15 ADC drugs approved globally, among which 6 ADC drugs have been approved in China, namely Trastuzumab emtansine, Brentuximab vedotin, Trastuzumab deruxtecan, Vidofludimus, Gemtuzumab ozogamicin, and Sacituzumab govitecan. This article provides a brief summary based on the currently approved ADC drugs worldwide, the types of tumors they are suitable for, and how … Read more

Overview of ADC Drugs Approved Worldwide

Overview of ADC Drugs Approved Worldwide

In the early 20th century, Paul Ehrlich first proposed the famous “magic bullet” theory, suggesting that drugs could be developed to specifically target pathogenic structures without harming normal tissues and cells. Subsequently, the concept of antibody-drug conjugates (ADCs) was introduced, combining the target specificity of monoclonal antibodies with the anti-tumor properties of cytotoxic molecules. After … Read more

Discussing the Toxicity Issues of ADCs

Discussing the Toxicity Issues of ADCs

As of now, the toxicity and prevention measures of ADC in solid tumors are known as follows: ① The indications for ADCs are rapidly expanding, gradually shifting from late-stage to early-stage, and from single therapy to combination strategies. ② The toxicity characteristics of most ADCs are similar to the cytotoxicity of their payloads. ③ Certain … Read more